The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

North America held the largest oncology molecular diagnostics market share in 2022.

The global oncology molecular diagnostics market is expected to grow from $3.66 billion in 2022 to $4.19 billion in 2023 at a compound annual growth rate (CAGR) of 14.4%. The oncology molecular diagnostics market is expected to grow from $7.11 billion in 2027 at a CAGR of 14.2%.

Major Driver In The Oncology Molecular Diagnostics Market ­– Rise In The Number Of Cancer Cases
According to the American Cancer Society, there will be 1.8 million new cancer cases and 0.6 million cancer deaths in the United States in 2021. Lung, prostate, bowel, and female breast cancer are the four most frequent kinds of cancer worldwide, accounting for 43% of all new cancer cases. As a result, the global increase in cancer incidence rate is expected to drive demand for the oncology molecular diagnostic market in the approaching years.

View More On The Oncology Molecular Diagnostics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/oncology-molecular-diagnostics-global-market-report

Key Oncology Molecular Diagnostics Market Segments
1) By Product: Instruments, Reagents, Other Products
2) By Technology: Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), Isothermic Nucleic Acid Amplification Technology (INNAT), Chips & Microarrays, Sequencing, Mass Spectroscopy, Transcription Mediated Amplification (TMA), Other Technologies
3) By End User: Hospitals, Diagnostic Centers, Academic & Research Institutes, Other End Users

Recent Oncology Molecular Diagnostics Market Trend – Advanced Technology In Genomics
Advancements in cancer genome sequencing technology, computational analysis, tumor models, and innovation of modern cancer research methods promote early detection of cancer and its mutation.

Oncology Molecular Diagnostics Market Prominent Players
Major players in the oncology molecular diagnostics market are Abbott Diagnostics, Becton Dickinson, Cepheid, Danaher Corporation, Beckman Coulter, Leica Biosystems, Gen-Probe (Hologic), Qiagen N.V., Roche Diagnostics, and Siemens Healthcare.

Request A Sample Of The Global Oncology Molecular Diagnostics Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3457&type=smp

The Oncology Molecular Diagnostics Global Market Report 2023  provides a comprehensive overview on the oncology molecular diagnostics market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the oncology molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The oncology molecular diagnostics refers to procedure for diagnosing cancers and related services. Molecular diagnostics are tests that diagnose genetic information, proteins, or related molecules and provide health or disease information.

View More Related Reports –
Oncology Drugs Market 2023 
Interventional Oncology Devices Global Market Report 2023
Oncology Biosimilars Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model